Reviva Pharmaceuticals Holdings
Tracked across 3 events · 99 articles · First seen May 13, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Reviva Pharmaceuticals Holdings reported its Q1 2026 financial results, including a reduced net loss and increased cash, and provided updates on its brilaroxazine development program, including a new patent application and upcoming Phase 3 trial. Its stock will transition from Nasdaq-100 to OTCQB Venture Market.
May 13, 2026 · 6 articles
International
Impact: Reviva Pharmaceuticals Holdings is building overseas industrial ecosystems, accelerating the global expansion of Chinese TCM and heritage wellness brands.
Jun 15, 2026 · 87 articles
Business
Impact: Reviva Pharmaceuticals Holdings was one of the presenting companies at the Life Sciences Virtual Investor Forum.
Jun 26, 2026 · 6 articles
60
Reviva Pharmaceuticals Holdings built ecosystems4th China International...
ERGEN INTELLIGENCE
Track Reviva Pharmaceuticals Holdings live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard